# Biocryst Pharmaceuticals Inc: Form 8-K, filed May 1, 2025

- Company: [Biocryst Pharmaceuticals Inc](/companies/bcrx.md) (CIK 882796)
- Form: 8-K
- Filed: 2025-05-01
- Accepted by EDGAR: May 1, 2025, 07:14 ET
- Period: 2025-04-30
- Accession: 0001171843-25-002669
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/882796/000117184325002669/f8k_050125.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/882796/000117184325002669/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/882796/000117184325002669/f8k_050125.htm

Filed May 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001171843-25-002669. Last ingested by Listed: Nov 10, 2026, 16:39 ET. No prices; not investment advice.